Editorial: The burden of stress and depression – new insight into faster and efficient treatment

Editorial: The burden of stress and depression – new insight into faster and efficient treatment

Bibliographic Details
Main Authors:	Keren Nitzan, Matthew O. Parker, Alon Shamir, Gang Chen, Ravid Doron
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	depression stress herbal treatment noradrenergic agents ketamin microbiome
Online Access:	https://www.frontiersin.org/articles/10.3389/fnbeh.2022.998307/full

Similar Items

PTSD: from neurobiology to pharmacological treatments
by: Benjamin Kelmendi, et al.
Published: (2016-11-01)

The molecular pathophysiology of depression and the new therapeutics
by: Haihua Tian, et al.
Published: (2022-09-01)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
by: Keren Nitzan, et al.
Published: (2023-08-01)

Effect of Pretreatment of S-Ketamine On Postoperative Depression for Breast Cancer Patients
by: Peirong Liu, et al.
Published: (2021-07-01)

Intravenous ketamine therapy in a patient with a treatment-resistant major depression
by: M Liebrenz, et al.
Published: (2007-04-01)

Depression and/or PTSD Comorbidity Affects Response to Antidepressants in Those With Alcohol Use Disorder
by: Peter J. Na, et al.
Published: (2022-01-01)

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
by: Carson Chrenek, et al.
Published: (2024-01-01)

Intramuscular ketamine in acute depression: A case report
by: C Harihar
Published: (2011-01-01)

Anoxia at Birth Induces Behaviorally-Relevant Changes in alpha2-Noradrenergic Receptor Binding in the Adult Rat
by: Wayne G. Brake, et al.
Published: (2020-12-01)

Perioperative Sedation and Sympatholysis Due to Tizanidine
by: Situ, et al.
Published: (2020-09-01)

Locus coeruleus inhibition of vibrissal responses in the trigeminal subnucleus caudalis are reduced in a diabetic mouse model
by: Alberto Mesa-Lombardo, et al.
Published: (2023-07-01)

Comparison of two anesthetic induction methods:ketamin and thiopental Na for ECT in major depression disorder patients
by: Ali Barkhori, et al.
Published: (2014-05-01)

Intravenous Ketamine Therapy vs. Electroconvulsive Therapy in Depressive Cases
by: Gholam Reza Kheirabadi, et al.
Published: (2012-01-01)

Safety of Repeated Administration of Parenteral Ketamine for Depression
by: David Feifel, et al.
Published: (2020-07-01)

Simulation of Cholinergic and Noradrenergic Modulation of Behavior in Uncertain Environments
by: Michael C Avery, et al.
Published: (2012-01-01)

Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial
by: Gholamreza Kheirabadi, et al.
Published: (2019-01-01)

Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
by: Hewa Artin, et al.
Published: (2022-06-01)

Do baseline anxiety symptoms impact response to IV Ketamine in treatment resistant depression?
by: Zoe Schreiber, et al.
Published: (2021-12-01)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
by: Natalia Górska, et al.
Published: (2021-05-01)

The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

Subcutaneous Ketamine in Depression: A Systematic Review
by: Vitor Breseghello Cavenaghi, et al.
Published: (2021-05-01)

Efficacy of Electroconvulsive Therapy and Ketamine Therapy in Major Depressive Disorder; A Comparative Study
by: Asif Azeem Bajwa, et al.
Published: (2023-02-01)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
by: Ryan Yip, et al.
Published: (2022-09-01)

Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder
by: Joshua Willms, et al.
Published: (2022-12-01)

Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression
by: Aleksander Kwaśny, et al.
Published: (2024-02-01)

Depression, an unmet health need in Africa: Understanding the promise of ketamine
by: Aletta ME. Millen, et al.
Published: (2024-04-01)

The impact of depressive symptoms on cognitive impairments in chronic ketamine users
by: Chenxi Zhang, et al.
Published: (2024-02-01)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
by: Maria Gałuszko-Węgielnik, et al.
Published: (2023-01-01)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
by: Ana Paula Anzolin, et al.
Published: (2023-03-01)

Menin Reduces Parvalbumin Expression and is Required for the Anti‐Depressant Function of Ketamine
by: Lige Leng, et al.
Published: (2024-02-01)

Nutritional therapy can reduce the burden of depression management in low income countries: A review
by: Moses B. Ekong, et al.
Published: (2021-12-01)

A study of tyrosine hydroxylase activity in nonadrenergic neurones in the rat brain
by: Graham-Jones, S
Published: (1981)

The Alpha-1 Adrenergic Receptor Antagonist Prazosin Reduces Binge-Like Eating in Rats
by: Callum Hicks, et al.
Published: (2020-05-01)

The modulation effects of repeated transcutaneous auricular vagus nerve stimulation on the functional connectivity of key brainstem regions along the vagus nerve pathway in migraine patients
by: Yiting Huang, et al.
Published: (2023-06-01)

Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
by: Donald B. Hoover, et al.
Published: (2017-12-01)

Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression
by: Yu Yang, et al.
Published: (2018-10-01)

919 Syrup Alleviates Postpartum Depression by Modulating the Structure and Metabolism of Gut Microbes and Affecting the Function of the Hippocampal GABA/Glutamate System
by: Xin-Yun Tian, et al.
Published: (2021-08-01)

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
by: Alina Wilkowska, et al.
Published: (2022-02-01)

Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study
by: Sachin Ahuja, et al.
Published: (2022-10-01)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
by: Wei Zheng, et al.
Published: (2020-11-01)